Theramex: Safety results from large real-world safety study in combined oral contraception published

The real world PRO-E2 safety study of over 101,000 women in 12 countries has confirmed that the risk of venous thromboembolism (VTE) is at least as low with Zoely? (NOMAC-E2) as with levonorgestrel-containing

Related Keywords

United States ,Canada ,Andrew Bradley ,Kostenloser Wertpapierhandel ,Van Vliet ,Reproductive Health Care ,Head Of Communications ,Eurj Contracept Reprod Health Care ,Drug Administration ,Donna Gregory Makara Health ,Womens Health Lond ,Industry Trade Media ,European Journal ,Marketing Authorisations ,Nomegestrol Acetate ,Accessed October ,Database Syst Rev ,Prospective Controlled Cohort Study ,Safety Communication ,Cochrane Database Syst Rev ,Sexual Reproductive ,Combined Oral ,Amended November ,Gregory Makara Health ,Theramex ,Safety ,Results ,Rom ,Barge ,Meal ,World ,Study ,Combined ,Mural ,Contraception ,Published ,